Fractyl Health Inc (NASDAQ: GUTS) kicked off on Monday, down -5.16% from the previous trading day, before settling in for the closing price of $1.55. Over the past 52 weeks, GUTS has traded in a range of $0.82-$3.48.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -12.32%. While this was happening, its average annual earnings per share was recorded 8.19%. With a float of $104.69 million, this company’s outstanding shares have now reached $132.19 million.
Fractyl Health Inc (GUTS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Fractyl Health Inc is 20.81%, while institutional ownership is 9.61%. The most recent insider transaction that took place on Mar 14 ’25, was worth 22,980. In this transaction Director of this company bought 17,901 shares at a rate of $1.28, taking the stock ownership to the 17,901 shares. Before that another transaction happened on Mar 14 ’25, when Company’s Director bought 31,000 for $1.30, making the entire transaction worth $40,210. This insider now owns 31,000 shares in total.
Fractyl Health Inc (GUTS) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.43 earnings per share (EPS), higher than consensus estimate (set at -0.5) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.84% during the next five years compared to -12.32% drop over the previous five years of trading.
Fractyl Health Inc (NASDAQ: GUTS) Trading Performance Indicators
Take a look at Fractyl Health Inc’s (GUTS) current performance indicators. Last quarter, stock had a quick ratio of 1.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9716.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.05, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.01 in one year’s time.
Technical Analysis of Fractyl Health Inc (GUTS)
The latest stats from [Fractyl Health Inc, GUTS] show that its last 5-days average volume of 6.03 million was superior to 1.14 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 76.71%.
During the past 100 days, Fractyl Health Inc’s (GUTS) raw stochastic average was set at 29.25%, which indicates a significant decrease from 68.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1419 in the past 14 days, which was higher than the 0.1394 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1784, while its 200-day Moving Average is $1.5224. Now, the first resistance to watch is $1.5867. This is followed by the second major resistance level at $1.7033. The third major resistance level sits at $1.7767. If the price goes on to break the first support level at $1.3967, it is likely to go to the next support level at $1.3233. Assuming the price breaks the second support level, the third support level stands at $1.2067.
Fractyl Health Inc (NASDAQ: GUTS) Key Stats
The company with the Market Capitalisation of 194.32 million has total of 50,289K Shares Outstanding. Its annual sales at the moment are 90 K in contrast with the sum of -68,690 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -27,890 K.
